<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-pharmaceuticals-13-00455">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hsieh</surname>
    <given-names>Y.-W.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>S.-Y.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>Y.-H.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>C.-P.</given-names>
   </name>
   <name>
    <surname>Chao</surname>
    <given-names>P.-D.L.</given-names>
   </name>
   <name>
    <surname>Hou</surname>
    <given-names>Y.-C.</given-names>
   </name>
  </person-group>
  <article-title>Oral intake of curcumin markedly activated CYP 3A4: In vivo and ex-vivo studies</article-title>
  <source>Sci. Rep.</source>
  <year>2014</year>
  <volume>4</volume>
  <fpage>6587</fpage>
  <pub-id pub-id-type="doi">10.1038/srep06587</pub-id>
  <pub-id pub-id-type="pmid">25300360</pub-id>
 </element-citation>
</ref>
